• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种半胱氨酸缺乏且 C 端截断的 GLP-1 受体。

Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.

机构信息

Department of Incretin Biology, Novo Nordisk, DK-2820 Gentofte, Denmark; Department of Chemistry, MEMPHYS - Center for Biomembrane Physics, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.

出版信息

Peptides. 2013 Nov;49:100-8. doi: 10.1016/j.peptides.2013.09.001. Epub 2013 Sep 14.

DOI:10.1016/j.peptides.2013.09.001
PMID:24045233
Abstract

The glucagon-like peptide-1 receptor (GLP-1R) belongs to family B of the G-protein coupled receptors (GPCRs), and has become a promising target for the treatment of type 2 diabetes. Here we describe the development and characterization of a fully functional cysteine-deprived and C-terminally truncated GLP-1R. Single cysteines were initially substituted with alanine, and functionally redundant cysteines were subsequently changed simultaneously. Our results indicate that Cys(174), Cys(226), Cys(296) and Cys(403) are important for the GLP-1-mediated response, whereas Cys(236), Cys(329), Cys(341), Cys(347), Cys(438), Cys(458) and Cys(462) are not. Extensive deletions were made in the C-terminal tail of GLP-1R in order to determine the limit for truncation. As for other family B GPCRs, we observed a direct correlation between the length of the C-terminal tail and specific binding of (125)I-GLP-1, indicating that the membrane proximal part of the C-terminal is involved in receptor expression at the cell surface. The results show that seven cysteines and more than half of the C-terminal tail can be removed from GLP-1R without compromising GLP-1 binding or function.

摘要

胰高血糖素样肽-1 受体(GLP-1R)属于 G 蛋白偶联受体(GPCR)家族 B,已成为治疗 2 型糖尿病的有前途的靶点。在这里,我们描述了一种完全功能性的半胱氨酸缺乏和 C 末端截断的 GLP-1R 的开发和特性。最初用丙氨酸替代单个半胱氨酸,然后同时改变功能冗余的半胱氨酸。我们的结果表明,Cys(174)、Cys(226)、Cys(296)和 Cys(403)对 GLP-1 介导的反应很重要,而 Cys(236)、Cys(329)、Cys(341)、Cys(347)、Cys(438)、Cys(458)和 Cys(462)则不是。为了确定截断的极限,我们在 GLP-1R 的 C 末端尾部进行了广泛的缺失。与其他家族 B GPCR 一样,我们观察到 C 末端尾部的长度与(125)I-GLP-1 的特异性结合之间存在直接相关性,这表明 C 末端的膜近端部分参与了细胞表面受体的表达。结果表明,GLP-1R 可以去除七个半胱氨酸和 C 末端尾部的一半以上而不影响 GLP-1 结合或功能。

相似文献

1
Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.开发一种半胱氨酸缺乏且 C 端截断的 GLP-1 受体。
Peptides. 2013 Nov;49:100-8. doi: 10.1016/j.peptides.2013.09.001. Epub 2013 Sep 14.
2
Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.B类G蛋白偶联受体激活中细胞外结构域的差异需求
J Biol Chem. 2016 Jul 15;291(29):15119-30. doi: 10.1074/jbc.M116.726620. Epub 2016 May 13.
3
Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.胰高血糖素样肽-1受体相互作用与转运的功能后果
J Biol Chem. 2015 Jan 9;290(2):1233-43. doi: 10.1074/jbc.M114.592436. Epub 2014 Dec 1.
4
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.胰高血糖素样肽-1(GLP-1)和艾塞那肽-4(exendin-4)的不同结构特性决定了它们对GLP-1受体N端细胞外结构域的相对亲和力。
Biochemistry. 2007 May 15;46(19):5830-40. doi: 10.1021/bi062309m. Epub 2007 Apr 20.
5
Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.胰高血糖素样肽-1受体的第一和第三细胞内环中的点突变会改变细胞内信号传导。
Biochem Biophys Res Commun. 1996 Jun 25;223(3):624-32. doi: 10.1006/bbrc.1996.0945.
6
Characterization of glucagon-like peptide-1 receptor-binding determinants.胰高血糖素样肽-1受体结合决定簇的表征
J Mol Endocrinol. 2000 Dec;25(3):321-35. doi: 10.1677/jme.0.0250321.
7
Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for F-NMR studies in solution.设计并制备 B 类 G 蛋白偶联受体 GLP-1R 和 GCGR,用于溶液中的 F-NMR 研究。
FEBS J. 2021 Jul;288(13):4053-4063. doi: 10.1111/febs.15686. Epub 2021 Jan 9.
8
A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.一种双重 GLP-1/GIP 受体激动剂不会在其受体上拮抗胰高血糖素,而是可能在 GLP-1 受体上作为一种偏向激动剂发挥作用。
Int J Mol Sci. 2019 Jul 19;20(14):3532. doi: 10.3390/ijms20143532.
9
Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket.胰高血糖素样肽-1(GLP-1)受体中半胱氨酸 226 和半胱氨酸 296 的功能偶联表明存在一个靠近激活口袋的二硫键。
Peptides. 2010 Dec;31(12):2289-93. doi: 10.1016/j.peptides.2010.09.015. Epub 2010 Oct 1.
10
Peptide binding at the GLP-1 receptor.肽与胰高血糖素样肽-1受体的结合。
Biochem Soc Trans. 2007 Aug;35(Pt 4):713-6. doi: 10.1042/BST0350713.

引用本文的文献

1
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.激动剂诱导的膜纳米域聚类驱动胰腺β细胞中的 GLP-1 受体反应。
PLoS Biol. 2019 Aug 20;17(8):e3000097. doi: 10.1371/journal.pbio.3000097. eCollection 2019 Aug.
2
An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain.胰高血糖素样肽-1受体胞外域激活的内在激动剂机制。
Cell Discov. 2016 Nov 22;2:16042. doi: 10.1038/celldisc.2016.42. eCollection 2016.
3
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
胰高血糖素样肽-1及其B类G蛋白偶联受体:通往治疗成功的漫长征程。
Pharmacol Rev. 2016 Oct;68(4):954-1013. doi: 10.1124/pr.115.011395.
4
A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.GLP-1R 上正位配体活性的增效剂通过共价修饰起作用。
Nat Chem Biol. 2014 Aug;10(8):629-31. doi: 10.1038/nchembio.1581. Epub 2014 Jul 6.